Arrowhead Prescription drugs Presents New Pivotal Section 3 Information at ESC 2024 from PALISADE Examine of Plozasiran in Sufferers with Familial Chylomicronemia Syndrome
- Plozasiran lowered triglycerides by 80% from baseline and lowered the chance…
GC Biopharma/Novel Pharma’s Sanfilippo Syndrome Remedy Obtains FDA IND Approval By Investing.com
YONGIN, South Korea, Could 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS)…
